Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Celltrion | Seoul | Healthcare | Biotechnology & Medical Research | ₩39.82T | 70.9x | 69.74 | ₩180,300 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.7% Upside | Upgrade to Pro+ | |
Peptron | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩6.86T | -187.2x | 11.42 | ₩294,500 | 3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LigaChem Biosciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩5.34T | 203.3x | 1.52 | ₩147,400 | 6.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.5% Upside | Upgrade to Pro+ | |
ABL Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.61T | -47.1x | 0.61 | ₩74,300 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.7% Upside | Upgrade to Pro+ | |
TissueGene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.58T | -94.3x | 1.09 | ₩43,900 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Voronoi | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩2.56T | -41.9x | 22.08 | ₩142,300 | 11.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seegene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.48T | 147.1x | 0.34 | ₩32,000 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.4% Upside | Upgrade to Pro+ | |
GI Innovation | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.33T | -17x | -38.89 | ₩21,450 | 4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OliX Pharmaceuticals | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩831.57B | -15.7x | 0.17 | ₩42,000 | 9.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curiox BioSystems | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩692.57B | -44x | 7.57 | ₩42,850 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AprilBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩518.13B | 17.4x | 0.08 | ₩23,000 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curocell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩505.62B | -12.3x | ₩35,300 | 4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Orum Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩484.59B | -19.2x | 0.34 | ₩23,000 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ImmuneOncia Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩465.61B | -50.5x | 0.51 | ₩6,300 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SillaJen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩422.68B | -15x | -4.18 | ₩3,060 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioneer | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩391.54B | -19.5x | 0.24 | ₩15,170 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intocell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩384.55B | -59.8x | -0.92 | ₩25,900 | -5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medipost | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩375.09B | -5.3x | 0 | ₩11,000 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
JS Link | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩349.12B | -12.8x | 0.12 | ₩12,890 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomictree | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩318.54B | -28.5x | -1.27 | ₩13,270 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Onconic Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩306.96B | -101.6x | ₩27,900 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Genexine | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩292.89B | -3.7x | ₩6,440 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Nibec | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩289.99B | -27.7x | ₩25,650 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Rokit Healthcare | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩270.68B | -15x | 0.85 | ₩17,560 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AptaBio Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩270.16B | -7.1x | 0.08 | ₩10,050 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OrganoidSciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩263.16B | -11x | -0.29 | ₩40,200 | 12.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ToolGen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩254.4B | 36x | 0.33 | ₩29,650 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abion | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩244.85B | -2.6x | 0.17 | ₩8,550 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vaxcell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩233.74B | ₩10,050 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Amicogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩232.42B | -3.8x | 0.12 | ₩4,240 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
3Billion | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩229.35B | -34.5x | 2.38 | ₩7,230 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GeneOne Life Science | Seoul | Healthcare | Biotechnology & Medical Research | ₩203.72B | -4.4x | -0.12 | ₩2,405 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Prestige Biopharma | Seoul | Healthcare | Biotechnology & Medical Research | ₩193.51B | 32.8x | 0.05 | ₩16,100 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Macrogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩173.03B | -20.7x | -0.36 | ₩15,960 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bridge Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩149.53B | -1.9x | -0.13 | ₩2,865 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medpacto | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩147.9B | -9.2x | -0.16 | ₩4,315 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tiumbio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩143.11B | -6.6x | 0.48 | ₩5,280 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CJ Bioscience | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩140.85B | -3x | 0.8 | ₩10,780 | -4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
iNtRON Biotechnology | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩138.47B | -31x | -0.64 | ₩4,380 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HEM Pharma | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩137.68B | ₩19,570 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
ENCell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩135.95B | -7.1x | 0.04 | ₩12,470 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OnCoCross | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩135.25B | -19x | 1.4 | ₩11,320 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB BioStep | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩126.37B | -16.8x | 0.09 | ₩1,496 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellid | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩121.26B | ₩4,110 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Neoimmunetech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩112.91B | -0.1 | ₩1,142 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Dx Vx | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩103.36B | -1.7x | 0.27 | ₩2,100 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Panagene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩97.7B | -29.5x | ₩2,165 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Cell Biotech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩94.99B | 6.5x | 0.06 | ₩13,880 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genome | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩94.34B | -4.3x | -0.08 | ₩3,040 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GL Pharm Tech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩93.05B | -141.7x | -1.55 | ₩1,209 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |